8-K - Ariad Pharmaceuticals Inc | Modeledge

Ariad Pharmaceuticals Inc

Filing type: 8-K
Filing date: Feb 15, 2017
Updated: Feb 16, 2017 · 9:13 AM

Filing

8-KMaterial Contracts, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events

Exhibits

EX-3.1EX-3.1 EX-3.2EX-3.2 EX-4.1EX-4.1 EX-99.1Material Contracts, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events